Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank

View ORCID ProfileXiude Fan, Zhengwen Liu, Kyle L Poulsen, Xiaoqin Wu, Tatsunori Miyata, View ORCID ProfileSrinivasan Dasarathy, View ORCID ProfileDaniel M. Rotroff, Laura E. Nagy
doi: https://doi.org/10.1101/2020.11.25.20238915
Xiude Fan
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
2Department of Infectious Diseases, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiude Fan
Zhengwen Liu
2Department of Infectious Diseases, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyle L Poulsen
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoqin Wu
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsunori Miyata
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srinivasan Dasarathy
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
4Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH
5Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Srinivasan Dasarathy
Daniel M. Rotroff
3Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel M. Rotroff
Laura E. Nagy
1Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
4Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH
5Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nagyL3@ccf.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Acute and chronic alcohol abuse have adverse impacts on both the innate and adaptive immune response, which may result in reduced resistance to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and promote the progression of coronavirus disease 2019 (COVID-19). However, there are no large population-based data evaluating potential causal associations between alcohol consumption and COVID-19.

Method We conducted a Mendelian randomization study using data from UK Biobank to explore the association between alcohol consumption and risk of SARS-CoV-2 infection and serious clinical outcomes in patients with COVID-19. A total of 12,937 participants aged 50-83 who tested for SARS-CoV-2 between 16 March to 27 July 2020 (12.1% tested positive) were included in the analysis. The exposure factor was alcohol consumption. Main outcomes were SARS-CoV-2 positivity and death in COVID-19 patients. We generated weighted and unweighted allele scores using three genetic variants (rs1229984, rs1260326, and rs13107325) and applied the allele scores as the instrumental variables to assess the effect of alcohol consumption on outcomes. Analyses were conducted separately for white participates with and without obesity.

Results Of the 12,937 participants, 4,496 were never or infrequent drinkers and 8,441 were frequent drinkers. (including 1,156 light drinkers, 3,795 moderate drinkers, and 3,490 heavy drinkers). Both logistic regression and Mendelian randomization analyses found no evidence that alcohol consumption was associated with risk of SARS-CoV-2 infection in participants either with (OR=0.963, 95%CI 0.800-1.159; q =1.000) or without obesity (OR=0.891, 95%CI 0.755-1.053; q =.319). However, frequent drinking (HR=1.565, 95%CI 1.012-2.419; q =.079), especially heavy drinking (HR=2.071, 95%CI 1.235-3.472; q =.054), was associated with higher risk of death in patients with obesity and COVID-19, but not in patients without obesity. Notably, the risk of death in frequent drinkers with obesity increased slightly with the average amount of alcohol consumed weekly (HR=1.480, 95%CI 1.059-2.069; q =.099).

Conclusions Our findings suggested alcohol consumption may had adverse effects on the progression of COVID-19 in white participants with obesity, but was not associate with susceptibility to SARS-CoV-2 infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by NIH grants: 3R01AA027456-02S1, P50AA024333, U01AA021890 and U01AA026938 (LEN); RO1GM119174, R21AR71046, UO1DK061732, RO1DK113196 and the Mikati foundation grant (SD); KL2TR002547 (DMR); K99AA026648 (KLP). XF was supported by a fellowship from the China Scholarship Council (File:201806280215) and TM was supported by a JSPS Overseas Research Fellowship 201960331.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank has obtained Research Tissue Bank (RTB) approval from its ethics committee and this study was also approved by the Institutional Review Boards of the Cleveland Clinic (IRB number:19582).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This study used data from the UK Biobank (application number 59473). For details please contact access@ukbiobank.ac.uk. All other data are contained in the article and its supplementary information or available upon reasonable request.

https://www.ukbiobank.ac.uk/

  • Abbreviation

    COVID-19
    coronavirus disease 2019
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus-2
    HR
    hazard ratio
    OR
    odds ratio
    CI
    confidence interval
    N
    number of participants
    ADH1B
    alcohol dehydrogenase 1B
    BMI
    body mass index
    GERD
    gastroesophageal reflux disease
    COPD
    chronic obstructive pulmonary disease
    AIDS
    acquired immunodeficiency syndrome
    ICU
    intensive care unit
    ARDS
    acute respiratory distress syndrome
    RSV
    respiratory syncytial virus
    FDR
    false discovery rate
    SNP
    single nucleotide polymorphism
    PSM
    propensity score matching
    RAF
    risk allele frequency
    GERA
    Genetic Epidemiology Research in Adult Health and Aging
    ADH1B
    alcohol dehydrogenase 1B
    GCKR
    glucokinase regulator
    SLC39A8
    solute carrier family 39 member 8
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 30, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank
    Xiude Fan, Zhengwen Liu, Kyle L Poulsen, Xiaoqin Wu, Tatsunori Miyata, Srinivasan Dasarathy, Daniel M. Rotroff, Laura E. Nagy
    medRxiv 2020.11.25.20238915; doi: https://doi.org/10.1101/2020.11.25.20238915
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank
    Xiude Fan, Zhengwen Liu, Kyle L Poulsen, Xiaoqin Wu, Tatsunori Miyata, Srinivasan Dasarathy, Daniel M. Rotroff, Laura E. Nagy
    medRxiv 2020.11.25.20238915; doi: https://doi.org/10.1101/2020.11.25.20238915

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (141)
    • Anesthesia (44)
    • Cardiovascular Medicine (408)
    • Dentistry and Oral Medicine (67)
    • Dermatology (47)
    • Emergency Medicine (141)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
    • Epidemiology (4805)
    • Forensic Medicine (3)
    • Gastroenterology (177)
    • Genetic and Genomic Medicine (670)
    • Geriatric Medicine (70)
    • Health Economics (187)
    • Health Informatics (621)
    • Health Policy (314)
    • Health Systems and Quality Improvement (200)
    • Hematology (84)
    • HIV/AIDS (155)
    • Infectious Diseases (except HIV/AIDS) (5278)
    • Intensive Care and Critical Care Medicine (323)
    • Medical Education (91)
    • Medical Ethics (24)
    • Nephrology (73)
    • Neurology (677)
    • Nursing (41)
    • Nutrition (110)
    • Obstetrics and Gynecology (124)
    • Occupational and Environmental Health (203)
    • Oncology (437)
    • Ophthalmology (138)
    • Orthopedics (36)
    • Otolaryngology (88)
    • Pain Medicine (35)
    • Palliative Medicine (15)
    • Pathology (127)
    • Pediatrics (193)
    • Pharmacology and Therapeutics (129)
    • Primary Care Research (84)
    • Psychiatry and Clinical Psychology (765)
    • Public and Global Health (1796)
    • Radiology and Imaging (321)
    • Rehabilitation Medicine and Physical Therapy (138)
    • Respiratory Medicine (255)
    • Rheumatology (86)
    • Sexual and Reproductive Health (68)
    • Sports Medicine (61)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (28)
    • Urology (37)